Skip to main content
TheraVet SA logo

TheraVet SA — Investor Relations & Filings

Ticker · ALVET ISIN · BE0974387194 LEI · 984500804EBR3F1EFF71 BR Manufacturing
Open in API
Filings indexed 239 across all filing types
Latest filing 2022-05-30 M&A Activity
Country BE Belgium
Listing BR ALVET

About TheraVet SA

https://www.egeiro.com/

TheraVet SA is a veterinary biotechnology company specializing in the development and commercialization of treatments for osteoarticular diseases in companion animals. The company focuses on creating a portfolio of pharmaceutical products and solutions designed to manage bone and joint conditions, such as osteoarthritis. Its primary objective is to provide innovative therapeutic options to improve the mobility and quality of life for pets.

Recent filings

Filing Released Lang Actions
TheraVet ondertekent een distributieovereenkomst met Nuzoa, een toonaangevende Spaanse distributeur van diergeneeskundige producten en diensten
M&A Activity Classification · 99% confidence The document is a press release dated May 30, 2022, announcing that TheraVet has signed an exclusive distribution agreement with Nuzoa for its BIOCERA-VET® line in Spain. This type of announcement, detailing a significant commercial partnership or business development, does not fit the specific definitions for financial reports (10-K, IR, ER), capital changes (CAP, SHA), management changes (MANG), or shareholder actions (AGM-R, DVA). It is a general corporate announcement regarding business operations and market expansion. Since it is not a standard regulatory filing like a 10-K or a specific financial report, and it is not merely announcing the publication of another report (RPA), the most appropriate general category for significant, non-standard corporate news is 'Regulatory Filings' (RNS), which serves as a fallback for miscellaneous announcements that don't fit the highly specific categories provided.
2022-05-30 Dutch
Inside Information / Other news releases
Regulatory Filings Classification · 95% confidence The document is a press release dated May 30, 2022, announcing a significant business event: the signing of an exclusive distribution agreement between TheraVet and Nuzoa for veterinary products in Spain. This type of announcement, detailing strategic partnerships, commercial developments, and operational updates outside of mandatory periodic financial reporting (like 10-K or IR), typically falls under general corporate news or regulatory filings. Since it is a specific, material announcement that doesn't fit the definitions for Earnings Release (ER), Capital Update (CAP), or Director's Dealing (DIRS), it is best classified as a general Regulatory Filing (RNS), which serves as the catch-all for significant, non-standard announcements, or potentially a general announcement if RNS is reserved strictly for exchange-mandated filings. Given the context of a premium database classifying corporate actions, RNS is the most appropriate general category for material press releases that aren't covered by more specific codes like DIV or MANG. The length (5692 chars) is substantial enough that it is the primary document, not just an announcement of a document (ruling out RPA).
2022-05-30 English
Informations privilégiées / Autres communiqués
Regulatory Filings Classification · 95% confidence The document is a press release dated May 30, 2022, announcing a significant business development: TheraVet signing an exclusive distribution agreement with Nuzoa for its BIOCERA-VET® line in Spain. This type of announcement, detailing strategic partnerships, commercial progress, and operational updates outside of mandatory periodic financial reporting (like 10-K or IR), typically falls under general corporate news or regulatory updates. Since it is not a formal financial report (10-K, IR, ER, MRQ), a management discussion (MDA), or a specific transaction like M&A (TAR) or share repurchase (POS), it is best classified as a general Regulatory Filing (RNS) or potentially a Capital/Financing Update (CAP) if the distribution deal significantly impacts future revenue streams, but RNS is the most appropriate general category for non-standard, material corporate news releases that require public disclosure. Given the options, and since it is a material business announcement rather than a financial statement or a specific insider/governance filing, RNS (Regulatory Filings / General Regulatory Announcements) serves as the best fit for this type of press release.
2022-05-30 French
THERAVET - AGO 2022 - Convocation - FINAL.pdf
AGM Information Classification · 100% confidence The document is explicitly titled "CONVOCATION A L'ASSEMBLEE GENERALE ORDINAIRE DES ACTIONNAIRES DU 2 JUIN 2022" (Notice of the Ordinary General Meeting of Shareholders of June 2, 2022). The content details the agenda for this meeting, which includes deliberation on the annual report, approval of annual accounts, discharge of directors, confirmation/renewal of director mandates, and renewal of the auditor's mandate. This content is characteristic of materials distributed to shareholders in preparation for an Annual General Meeting (AGM). Therefore, the appropriate classification is AGM-R (AGM Information).
2022-05-12 French
Terms of availability of the preparatory documents for the GM
AGM Information Classification · 98% confidence The document explicitly announces the 'availability of the preparatory documents for the ordinary general meeting of the Company to be held on June 2, 2022'. This indicates an announcement about materials related to an AGM, rather than the AGM presentation itself (AGM-R) or the voting results (DVA). Since the document is short (2383 chars) and its primary function is to state that preparatory documents are available and where to find them, it fits the description of a Report Publication Announcement (RPA) or potentially an AGM-R related announcement. Given the focus is on the *availability* of preparatory documents for the AGM, and it is not the actual presentation or voting results, RPA is a strong candidate, but AGM-R materials are specifically mentioned. However, the definition for AGM-R is 'Presentations and materials shared during the Annual General Meeting (AGM)'. This document is an announcement *about* those materials. The closest fit for an announcement regarding meeting materials, especially when the actual materials aren't present, is often RPA, but since the subject matter is explicitly the AGM, and it's not a proxy statement (PSI), I will lean towards the most specific category related to the event being announced, which is AGM-R, interpreting 'preparatory documents' as the core material being referenced. Re-evaluating based on the 'MENU VS MEAL' rule: This is an announcement *about* the documents, not the documents themselves. Therefore, RPA (Report Publication Announcement) is the most appropriate classification for an announcement stating materials are available, even if the material relates to an AGM. If AGM-R was defined as 'Announcement of AGM materials', it would be AGM-R. Since RPA covers the publication announcement, I select RPA.
2022-05-12 English
Modalités de mise à disposition des documents préparatoires à l'AG
AGM Information Classification · 98% confidence The document is a short announcement (2666 characters) dated May 12, 2022, titled "Assemblée générale du 2 juin 2022 : mise à disposition des documents préparatoires" (General Meeting of June 2, 2022: availability of preparatory documents). It explicitly states that the preparatory documents for the Ordinary General Meeting (AGM) are being made available and directs shareholders to where they can be consulted or requested. According to Rule #2 (The 'Menu vs Meal' Rule), a short announcement stating that a report or related documents are available or published points towards a Report Publication Announcement (RPA) rather than the full AGM material itself (AGM-R). Since this is specifically about announcing the availability of AGM preparatory documents, RPA is the most precise fit among the options for an announcement of publication.
2022-05-12 French

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.